Turnstone Biologics

Turnstone Biologics

Turnstone Biologics

Turnstone Biologics is a privately-held clinical stage biotech company.
Founded
2015
Raised
$110.9M
Follow us
Alexa global traffic share
Latest funding
$80,000,000
Venture capital (Series D) - 2021
Versant Ventures OrbiMed Sectoral Asset Management +8
$30,895,100
Venture capital (Series B) - 2016
Versant Ventures OrbiMed F-Prime Capital Partners +1
Team Size
1–10
Employees
$80,000,000 Venture capital (Series D)
WSJ Venture Capital

Cancer Drugmaker Turnstone Biologics Raises $80 Million

$30,895,100 Venture capital (Series B)
Techvibes , Geektime

Biotech Firm Raises $41 Million to Advance Cancer-Fighting Technologies

BetaKit

Today in funding ($51M): Turnstone Biologics, Invixium and Qvella

Funding Apps & Services